Drug Information

Drug General Information
Drug ID
D0Y1YC
Former ID
DNC000549
Drug Name
Diazemuls
Drug Type
Small molecular drug
Indication Discovery agent Investigative [537354]
Structure
Download
2D MOL

3D MOL
Formula
C16H13ClN2O
Canonical SMILES
CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3
InChI
1S/C16H13ClN2O/c1-19-14-8-7-12(17)9-13(14)16(18-10-15(19)20)11-5-3-2-4-6-11/h2-9H,10H2,1H3
InChIKey
AAOVKJBEBIDNHE-UHFFFAOYSA-N
CAS Number
CAS 439-14-5
PubChem Compound ID
3016
PubChem Substance ID
9163, 118340, 442487, 589069, 597369, 866565, 3248698, 5349992, 7847359, 7849643, 7887249, 7945393, 7979063, 8027939, 8150113, 8151919, 10522913, 11336142, 11361381, 11372878, 11374151, 11462353, 11491595, 11492391, 14799843, 24893306, 24894120, 26719642, 29222163, 46386554, 46505210, 47440353, 47515391, 47662377, 48259330, 48413548, 48415873, 48423248, 49742658, 49854346, 50122777, 50660483, 53788455, 56313613, 57321555, 57654125, 81041007, 85788516, 85856297, 92308494
ChEBI ID
ChEBI:49575
SuperDrug ATC ID
N05BA01
SuperDrug CAS ID
cas=000439145
Target and Pathway
Target(s) Peripheral-type benzodiazepine receptor Target Info Agonist [537354]
KEGG Pathway Neuroactive ligand-receptor interaction
HTLV-I infection
References
Ref 537354The alpha5(H105R) mutation impairs alpha5 selective binding properties by altered positioning of the alpha5 subunit in GABAA receptors containing two distinct types of alpha subunits. J Neurochem. 2009 Jul;110(1):244-54. Epub 2009 Apr 27.
Ref 537354The alpha5(H105R) mutation impairs alpha5 selective binding properties by altered positioning of the alpha5 subunit in GABAA receptors containing two distinct types of alpha subunits. J Neurochem. 2009 Jul;110(1):244-54. Epub 2009 Apr 27.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.